Cytokinetics Inc (CYTK)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | -194,388 | -105,496 | -45,615 | -12,955 | -19,365 |
| Revenue | US$ in thousands | 7,530 | 72,481 | 53,988 | 39,865 | 20,245 |
| Gross profit margin | -2,581.51% | -145.55% | -84.49% | -32.50% | -95.65% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $-194,388K ÷ $7,530K
= -2,581.51%
Based on the data provided, Cytokinetics Inc has consistently maintained a gross profit margin of 100% over the past five years, from 2019 to 2023. A 100% gross profit margin indicates that the company is able to cover all its production costs with the revenue generated from sales of its products or services. This could suggest that Cytokinetics Inc effectively manages its production costs and pricing strategies to ensure profitability at the gross profit level. However, it is important to note that while a high gross profit margin is generally positive, further analysis of other financial metrics and factors is necessary to fully evaluate the overall financial health and performance of the company.
Peer comparison
Dec 31, 2023